Allurion Technologies Inc. focuses on developing a weight loss platform for overweight people in Spain, France, Turkey, and internationally. Its Allurion Program platform offers the Allurion Smart Capsule, a swallowable and procedure-less intragastric balloon for weight loss, and access to the Allurion Virtual Care Suite, a digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior change program. The company is headquartered in Natick, Massachusetts. Show more
11 Huron Drive, Natick, MA, 01760, United States
Market Cap
13.64M
52 Wk Range
$0.23 - $3.33
Previous Close
$0.91
Open
$0.73
Volume
6,376
Day Range
$0.73 - $0.91
Enterprise Value
37.27M
Cash
5.412M
Avg Qtr Burn
-5.32M
Insider Ownership
5.18%
Institutional Own.
1.18%
Qtr Updated
12/31/25
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|
